483 filings
Page 23 of 25
S-3
itzh6
30 Mar 07
Shelf registration
12:00am
S-8
p10 hbjrg7owv3x6cjx4
30 Mar 07
Registration of securities for employees
12:00am
10-K
48kuw1w
29 Mar 07
Annual report
12:00am
8-K
5qsn 6uyk3
26 Mar 07
Regulation FD Disclosure
12:00am
8-K
9q1nd15t3d225xdvr
16 Mar 07
Departure of Directors or Principal Officers
12:00am
8-K
wjgdob3zzb 2fx3o5yp
5 Mar 07
Departure of Directors or Principal Officers
12:00am
8-K
9v2s cnzqgr4cdd
9 Feb 07
Alexza Updates Status of Development Pipeline and Summarizes 2007 Corporate Goals
12:00am
8-K
erjir e5l72
18 Jan 07
Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
12:00am
8-K
tzinig0c
9 Jan 07
Entry into a Material Definitive Agreement
12:00am
8-K
wsbb60ons5luur2
21 Dec 06
Alexza Pharmaceuticals Announces Initial Results for the AZ-003 Phase I Clinical Trial
12:00am
8-K
zj8y87z8
13 Dec 06
Alexza Completes Enrollment in AZ-001 Phase IIb Clinical Trial in Patients with Migraine Headaches
12:00am
8-K
xulmbs
12 Dec 06
Other Events
12:00am
8-K
fqmkxs
4 Dec 06
Alexza Pharmaceuticals and Symphony Capital Enter into $50 Million Product Development Collaboration for AZ-002 and AZ-004
12:00am
8-K
fwv thdzgy1i7nx3i
13 Nov 06
Alexza Reports Third Quarter Financial Results and Updates Status of Development Pipeline
12:00am
UPLOAD
hc4w 4oinc6u7b
11 Oct 06
Letter from SEC
12:00am
8-K
c03o8t
4 Oct 06
Entry into a Material Definitive Agreement
12:00am
8-K
pttl5
22 Sep 06
Regulation FD Disclosure
12:00am